HealthCor Management as of Sept. 30, 2022
Portfolio Holdings for HealthCor Management
HealthCor Management holds 59 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| BioMarin Pharmaceutical (BMRN) | 8.0 | $64M | 759k | 84.77 | |
| Abbvie (ABBV) | 5.2 | $42M | 310k | 134.21 | |
| Agilent Technologies Inc C ommon (A) | 5.1 | $41M | 338k | 121.55 | |
| Boston Scientific Corporation (BSX) | 4.6 | $37M | 959k | 38.73 | |
| Eli Lilly & Co. (LLY) | 4.2 | $33M | 103k | 323.35 | |
| AmerisourceBergen (COR) | 4.0 | $32M | 239k | 135.33 | |
| UnitedHealth (UNH) | 4.0 | $32M | 63k | 505.03 | |
| Danaher Corporation (DHR) | 3.8 | $30M | 118k | 258.29 | |
| Tenet Healthcare Corp Com New (THC) | 3.3 | $27M | 519k | 51.58 | |
| Thermo Fisher Scientific (TMO) | 3.3 | $26M | 51k | 507.18 | |
| Centene Corporation (CNC) | 2.9 | $23M | 301k | 77.81 | |
| Cigna Corp (CI) | 2.7 | $21M | 77k | 277.47 | |
| Cytokinetics Com New (CYTK) | 2.6 | $21M | 435k | 48.45 | |
| Humana (HUM) | 2.6 | $21M | 43k | 485.18 | |
| Syndax Pharmaceuticals (SNDX) | 2.6 | $21M | 859k | 24.03 | |
| Dex (DXCM) | 2.6 | $20M | 254k | 80.54 | |
| Biogen Idec (BIIB) | 2.3 | $19M | 70k | 267.00 | |
| Anthem (ELV) | 2.2 | $18M | 39k | 454.23 | |
| Amgen (AMGN) | 2.1 | $17M | 75k | 225.39 | |
| Livanova SHS (LIVN) | 2.1 | $17M | 328k | 50.77 | |
| Henry Schein (HSIC) | 2.0 | $16M | 249k | 65.77 | |
| Bristol Myers Squibb (BMY) | 2.0 | $16M | 223k | 71.09 | |
| Incyte Corporation (INCY) | 1.9 | $15M | 228k | 66.64 | |
| Horizon Therapeutics Pub L SHS | 1.8 | $14M | 230k | 61.89 | |
| Becton, Dickinson and (BDX) | 1.8 | $14M | 63k | 222.83 | |
| Kezar Life Sciences (KZR) | 1.7 | $14M | 1.6M | 8.61 | |
| CVS Caremark Corporation (CVS) | 1.6 | $13M | 131k | 95.37 | |
| McKesson Corporation (MCK) | 1.5 | $12M | 35k | 339.87 | |
| Abbott Laboratories (ABT) | 1.2 | $9.6M | 99k | 96.76 | |
| Molina Healthcare (MOH) | 1.1 | $9.1M | 28k | 329.85 | |
| Hologic (HOLX) | 1.1 | $8.9M | 137k | 64.52 | |
| Seagen | 1.0 | $7.8M | 57k | 136.83 | |
| Rocket Pharmaceuticals (RCKT) | 0.9 | $7.1M | 445k | 15.96 | |
| Blueprint Medicines (BPMC) | 0.9 | $6.9M | 105k | 65.89 | |
| Inspire Med Sys (INSP) | 0.8 | $6.8M | 38k | 177.38 | |
| Alkermes SHS (ALKS) | 0.8 | $6.8M | 304k | 22.33 | |
| ImmunoGen | 0.8 | $6.2M | 1.3M | 4.78 | |
| Shockwave Med (SWAV) | 0.7 | $5.5M | 20k | 278.09 | |
| Merus N V (MRUS) | 0.7 | $5.5M | 273k | 20.03 | |
| Chinook Therapeutics | 0.7 | $5.2M | 267k | 19.66 | |
| Dentsply Sirona (XRAY) | 0.6 | $4.5M | 158k | 28.35 | |
| Geron Corporation (GERN) | 0.6 | $4.5M | 1.9M | 2.34 | |
| Affimed Therapeutics B V | 0.4 | $3.5M | 1.7M | 2.06 | |
| Cano Health Com Cl A | 0.4 | $3.4M | 396k | 8.67 | |
| Neogenomics Com New (NEO) | 0.4 | $3.4M | 391k | 8.61 | |
| Nevro (NVRO) | 0.4 | $3.1M | 68k | 46.60 | |
| Bluebird Bio (BLUE) | 0.4 | $2.9M | 455k | 6.33 | |
| Natera (NTRA) | 0.4 | $2.9M | 65k | 43.82 | |
| Neurocrine Biosciences (NBIX) | 0.3 | $2.3M | 22k | 106.22 | |
| Hyperfine Com Cl A (HYPR) | 0.3 | $2.2M | 2.7M | 0.81 | |
| Revance Therapeutics (RVNC) | 0.2 | $1.7M | 65k | 27.00 | |
| Iveric Bio | 0.2 | $1.5M | 85k | 17.94 | |
| Leap Therapeutics | 0.1 | $939k | 1.1M | 0.88 | |
| Ikena Oncology (IKNA) | 0.1 | $781k | 220k | 3.55 | |
| Eqrx *w Exp 12/17/202 | 0.0 | $29k | 35k | 0.82 | |
| Longview Acquisition Corp Ii *w Exp 99/99/999 | 0.0 | $10k | 150k | 0.07 | |
| Eucrates Biomedical Acqu Cor *w Exp 10/23/202 | 0.0 | $2.0k | 78k | 0.03 | |
| Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $1.0k | 30k | 0.03 | |
| Orion Acquisition Corp *w Exp 02/19/202 | 0.0 | $0 | 50k | 0.00 |
